Why aren’t Medicare drug price negotiations lowering all patients’ out-of-pocket costs?

Because lower negotiated Medicare drug prices are not translating evenly into beneficiary savings. The article says out-of-pocket relief depends on benefit design, cost-sharing structure, and product-level utilization, so some patients and products may see meaningful savings while others see little change.